These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1371426)

  • 21. Carcinoma-associated monoclonal antibodies in head and neck carcinoma. Immunohistochemistry and biodistribution of monoclonal antibodies 175F4 and 175F11.
    Balm AJ; Hageman PC; Mulder CL; Hilkens J
    Eur Arch Otorhinolaryngol; 1992; 249(5):237-42. PubMed ID: 1524802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.
    de Bree R; Roos JC; Quak JJ; den Hollander W; Snow GB; van Dongen GA
    Clin Cancer Res; 1995 Jun; 1(6):591-8. PubMed ID: 9816020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a high-affinity monoclonal antibody specific for CD44v6 as candidate for immunotherapy of squamous cell carcinomas.
    Heider KH; Sproll M; Susani S; Patzelt E; Beaumier P; Ostermann E; Ahorn H; Adolf GR
    Cancer Immunol Immunother; 1996 Dec; 43(4):245-53. PubMed ID: 9003471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicin.
    Desrues B; Léna H; Brichory F; Ramée MP; Toujas L; Delaval P; Dazord L
    Br J Cancer; 1995 Nov; 72(5):1076-82. PubMed ID: 7577450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer.
    Modjtahedi H; Hickish T; Nicolson M; Moore J; Styles J; Eccles S; Jackson E; Salter J; Sloane J; Spencer L; Priest K; Smith I; Dean C; Gore M
    Br J Cancer; 1996 Jan; 73(2):228-35. PubMed ID: 8546911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line.
    Harris M; Wang XG; Jiang Z; Goldberg GL; Casadevall A; Dadachova E
    Head Neck Oncol; 2011 Feb; 3(1):9. PubMed ID: 21314983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of squamous cell carcinoma xenografts in nude mice by radiolabeled monoclonal antibody E48.
    Quak JJ; Gerretsen M; Schrijvers AH; Meijer CJ; van Dongen GA; Snow GB
    Arch Otolaryngol Head Neck Surg; 1991 Nov; 117(11):1287-91. PubMed ID: 1747235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biodistribution of monoclonal antibody Po66 in a human lung tumour-bearing mouse model: effect of blood exchange on tumour antibody uptake.
    Desrues B; Quinquenel ML; Toujas L; Delaval P; Dazord L
    Nucl Med Biol; 1995 Jul; 22(5):569-72. PubMed ID: 7581165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancer.
    de Bree R; Roos JC; Quak JJ; den Hollander W; Wilhelm AJ; van Lingen A; Snow GB; Dongen GA
    Clin Cancer Res; 1995 Mar; 1(3):277-86. PubMed ID: 9815983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PET of EGFR antibody distribution in head and neck squamous cell carcinoma models.
    Niu G; Li Z; Xie J; Le QT; Chen X
    J Nucl Med; 2009 Jul; 50(7):1116-23. PubMed ID: 19525473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth of xenografted head and neck cancer in nude mice pre-treated with whole body irradiation.
    Zätterström UK; Wennerberg J
    Acta Otolaryngol; 1991; 111(6):1170-7. PubMed ID: 1763641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies against squamous cell carcinoma of the upper aerodigestive mucous membranes.
    Folz BJ; Görögh T; Lippert BM; Werner JA
    Otolaryngol Head Neck Surg; 2000 Jan; 122(1):124-8. PubMed ID: 10629499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A monoclonal antibody to squamous cell carcinoma.
    Ranken R; Kaplan MJ; Silverman S; Gottfried TG; White C; Fee WE; Yonkovich S; Boles R; Liu V
    Laryngoscope; 1987 Jun; 97(6):657-62. PubMed ID: 2438528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties.
    Martens-de Kemp SR; Brink A; Stigter-van Walsum M; Damen JM; Rustenburg F; Wu T; van Wieringen WN; Schuurhuis GJ; Braakhuis BJ; Slijper M; Brakenhoff RH
    Stem Cell Res; 2013 May; 10(3):477-88. PubMed ID: 23523931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck.
    Wolf GT; Carey TE; Schmaltz SP; McClatchey KD; Poore J; Glaser L; Hayashida DJ; Hsu S
    J Natl Cancer Inst; 1990 Oct; 82(19):1566-72. PubMed ID: 2119437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
    Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA
    J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of tumour volume and other characteristics on uptake of radiolabelled monoclonal antibodies in tumour tissue of head and neck cancer patients.
    de Bree R; Kuik DJ; Quak JJ; Roos JC; van den Brekel MW; Castelijns JA; van Wagtendonk FW; Greuter H; Snow GB; van Dongen GA
    Eur J Nucl Med; 1998 Nov; 25(11):1562-5. PubMed ID: 9799354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SQM1 antibody defines a surface membrane antigen in squamous carcinoma of the head and neck.
    Boeheim K; Speak JA; Frei E; Bernal SD
    Int J Cancer; 1985 Aug; 36(2):137-42. PubMed ID: 3894247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biodistribution of 131I-labeled anti-CK8 monoclonal antibody in HNSCC in xenotransplanted SCID mice.
    Andratschke M; Luebbers CW; Johannson V; Schmitt B; Mack B; Zeidler R; Lang S; Wollenberg B; Gildehaus FJ
    Anticancer Res; 2011 Oct; 31(10):3315-21. PubMed ID: 21965741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation.
    Liotta F; Querci V; Mannelli G; Santarlasci V; Maggi L; Capone M; Rossi MC; Mazzoni A; Cosmi L; Romagnani S; Maggi E; Gallo O; Annunziato F
    Br J Cancer; 2015 Feb; 112(4):745-54. PubMed ID: 25647013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.